February 7, 2018

ZeNix Clinical Trial Announced

New trial evaluates whether the efficacy of the BPaL drug regimen can be maintained with reduced toxicity
November 17, 2017

Ending TB Means Investing in R&D

Joint statement from Aeras, FIND, TB Alliance, and TBVI
November 6, 2017

Ariel Pablos-Méndez Joins TB Alliance Board of Directors

Dr. Pablos-Méndez brings decades of experience in strategies to improve the lives of the poor and most vulnerable people in the world
October 30, 2017

TB Alliance Statement on WHO’s Global Tuberculosis Report 2017

TB continues to be the leading cause of death from a single infectious agent worldwide.
October 10, 2017

TB Alliance Moves Two Novel Tuberculosis Drugs into Human Trials

TBA-7371 and Sutezolid Help Fill Sparse Pipeline of New Antibiotics Against a Disease That Grows Increasingly Resistant to Older Drugs
September 27, 2017

TB Alliance Endorses WHO Designation of TB as a “Global Priority Pathogen”

New reports call for increased research and development funding
August 31, 2017

WHO Prequalifies Childhood TB Medicine

TB Alliance led efforts to develop improved medicines for children with tuberculosis
June 22, 2017

An Open Letter to Dr. Tedros

TB Alliance Congratulates New WHO Director-General
May 11, 2017

EU Leaders Urge Funding of Critically-needed New Tools against Drug-resistant Tuberculosis

Participants at high-level meeting seek to end TB health threat in Europe

Pages